NEW YORK, Jan. 11 - Genetix Group has licensed the rights to manufacture and sell microarray scanners owned by Biomedical Photometrics, the company said.
The scanners, called aQuire, are intended to complement Genetix' existing arraying robots and to allow the company to sell what it calls complete systems for gene-expression analysis.
Genetix, of New Milford, UK, said it will now provide two platforms: a high-throughput array and analysis system based on the aQuire confocal scanner and its own QArray, and a system using the new smaller QArray Mini and the aQuire Mini scanner.
"We are very excited about this new opportunity to extend our product range into the area of high value data acquisition applications," Julian Burke, chief scientific officer of Genetix, said in a statement released on Thursday.
The aQuire scanners will be built in Genetix's Hampshire, UK facility, a company spokeswoman said. The units will be sold with the QArray line in Genetix' existing markets in Europe, the US, and Asia.
Biomedical Photometrics is based in Waterloo, Canada.